DNAtriX
DNAtrix is a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer. DNAtrix’s lead product, DNX-2401, is a modified common cold virus that targets and kills cancer cells selectively.
DNAtriX Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
Houston, Texas, USA
